A detailed history of J.W. Cole Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 3,989 shares of BSX stock, worth $334,756. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,989
Previous 3,653 9.2%
Holding current value
$334,756
Previous $250,000 22.8%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$67.33 - $77.71 $22,622 - $26,110
336 Added 9.2%
3,989 $307,000
Q1 2024

Apr 30, 2024

BUY
$57.6 - $68.62 $210,412 - $250,668
3,653 New
3,653 $250,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $1.42 Million - $1.57 Million
34,705 New
34,705 $45,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $340,284 - $430,822
-10,265 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$34.44 - $42.23 $353,526 - $433,490
10,265 New
10,265 $392,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.